EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics.

Ireton, Reneé C

EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics. [electronic resource] - Current cancer drug targets May 2005 - 149-57 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review

1568-0096

10.2174/1568009053765780 doi


Animals
Antineoplastic Agents--pharmacology
Humans
Neoplasms--drug therapy
Neovascularization, Pathologic--drug therapy
Receptor, EphA2--biosynthesis